Nuvama Contribution:

• Adding to our strong track record of bringing several 1st business stories and Healthcare IPOs to the Indian capital markets, Nuvama successfully leads the 1st IPO of a Dental Products Company in India – This is our 4th deal^@ in Pharma & Healthcare space in the last 45 days
• As the left-lead banker, hand-held the Company in end-to-end execution, swift regulatory approvals, thereby ensuring timely launch
• Nuvama leveraged its domain expertise by uniquely positioning Laxmi Dental as one of India’s Largest and only end-to-end integrated dental products company with a comprehensive portfolio of products
• Nuvama garnered participation from a diverse investor set including Sovereign Wealth Fund, Marquee ‘Long Only’ FIIs, and Mutual Fund – Procured 3 out of 5 largest FII bids in the Anchor Segment
• Pushed the story aggressively through our distribution channel to garner strong interest in HNI & Retail category resulting in 32 lakh+ applications^#

Deal Details:

• Highest subscribed Healthcare IPO in India over the last 2 decades^$
• Deal saw strong participation across investor categories garnering more than INR 44,000 crs^# – QIB – ~110x*, HNI – ~147x*, Retail – ~75x*
• Company saw stellar IPO Listing with equity shares opening at 27%^{^} premium showcasing investor confidence in Company’s business and management team

*After technical Rejections; #Before Technical Rejections; ^NSE Prices are considered on listing day; $Since Jan, 2000
@IPO and QIP deals;